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Cannabis arteritis (CA) is a major and underdiagnosed
cause of peripheral arterial disease in young patients.
A 34-year-old man, daily smoker of 20 cigarettes and
two cannabis cigarettes for 14 years, presented with a
necrotic plaque of left hallux for 3 weeks. The Doppler
ultrasound and angiography were compatible with severe
Buerger’s disease. Submitted to a revascularisation
procedure and hypocoagulation with rivaroxaban. He
had ceased smoking but maintained consumption of
cannabis. Owing to the persistence of distal necrosis,
amputation of the hallux was performed with good
evolution. CA is a subtype of Buerger’s disease. It is
poorly known but increasingly prevalent and manifests in
cannabis users regardless of tobacco use. The drug is
considered at least a cofactor of the arteriopathy. The
most effective treatment is cessation of consumption.
Being cannabis one of the most consumed drugs, its
mandatory to ask about its use in all young patients
with arteriopathy.
BACKGROUND
Cannabis is one of the most used drugs in the
world and has been associated with arterial diseases
like stroke, myocardial infarction and arteritis.1–3
Cannabis arteritis (CA) was first described by Stern
and Ducastaing in 19604 but fewer than 100 cases
were reported in the literature since then. The
authors present a possible case of CA highlighting
the importance of the clinical suspicion and close
clinical follow-up in this diagnosis. The condition
is likely widely underdiagnosed.
CASE PRESENTATION
The authors present a 34-year-old man admitted
for a painful necrosis of the left hallux. The patient
revealed that the necrotic lesion had arisen 3 weeks
before but referred a previously erythematous and
oedematous plaque of the distal extremity of the
left leg with about 6 months of evolution. This
plaque had been previously treated for a cellulitis
without any improvement. He had no cardiovascu-
lar risk factors. The patient had no relevant per-
sonal or family background. He smoked tobacco
(∼20 cigarettes a day) and cannabis (about two
cigarettes a day) for over 14 years. He denied using
other drugs.
The clinical observation revealed an erythema-
tous and oedematous plaque of the distal left leg
that condition an evident asymmetry of colour and
volume relative to the contralateral limb. On the
pulp of the left hallux we noticed an exudative
ulcerated lesion partially covered by a necrosis
plaque (figure 1). No clinical signs of infection
were present. He presented no signs of
claudication. The pedal pulses were not palpable in
both feet and neither was the left popliteal pulse.
A prompt search for thrombophilic factors and
immunologic diseases proved negative. Blood
glucose, calcium and lipids were normal.
Doppler ultrasonography of the lower limbs was
performed and showed supragenicular popliteal
occlusion of the left lower limb and absence of
Doppler signal in the anterior tibial artery of the
same leg. The Ankle-Brachial Index was 0.67 on
the left and normal on the right.
Lower limb arteriography showed permeability of
the aortoiliac sector bilaterally but occlusion of the
peroneal and anterior tibial arteries as of the plantar
arch in both legs (figures 2 and 3). Additionally, it
showed occlusion of the supra-articular popliteal
artery in the left leg (figure 4).
Attending to the clinical features including the
patient’s young age, heavy smoking and the arterio-
graphic findings, a presumable diagnosis of throm-
boangiitis obliterans (Buerger’s disease) was made.
The patient agreed to a revascularisation proced-
ure and an autoexpandable stent was placed on the
left popliteal artery. After the procedure, the left
distal pulses were palpable. Hypocoagulation was
initiated with rivaroxaban 20 mg a day. The need
to stop his smoking habits was explained to the
patient.
After a 2-month follow-up, however, the necrotic
lesion had not improved, there was a recurrence of
the pain and the left distal pulses weren’t palpable.
The patient admitted to maintain consumption of
cannabis but affirmed to stop smoking tobacco
since he was instructed to do so.
After 6 months of the revascularisation proced-
ure, the lesion and the pain were still maintained
and clinical signs of infection showed and amputa-
tion of the left hallux was finally required. The
patient was instructed to cease the cannabis use.
OUTCOME AND FOLLOW-UP
After a 6-month follow-up, the patient declared
that he had stopped smoking cannabis, and there
was complete resolution of the pain and a good
clinical outcome of the left hallux stump.
Attending to this clinical evolution of absence of
improvement with tobacco smoking cessation and
progression of the disease with maintenance of can-
nabis use, a presumable diagnosis of CA was made.
DISCUSSION
When peripheral arterial disease is found in a
young individual, the main causes for juvenile
arteritis should be considered: atherosclerotic
disease, systemic and autoimmune diseases and
thromboangiitis obliterans (or Buerger’s disease).5
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In our patient, there was no cardiovascular risk factor other
than smoking and the screening for systemic and autoimmune
diseases was negative. Our patient met the criteria for
thromboangiitis obliterans as he was <45 years old, presented
peripheral ischaemia without other cause of arterial disease, was
a tobacco smoker and presented compatible arteriographic
findings.5 However, the clinical course was not compatible with
Buerger’s disease because even with smoke cessation, the disease
continued to evolve. This outcome gives room to consider
cannabis at least as a cofactor of the arteriopathy.
CA was first described in 19604 but since then fewer than 100
cases were described in the literature. However, CA seems to be
an underdiagnosed disease because of its clinical and imagiologi-
cal resemblance to Buerger’s disease.
This pathology seems to be more frequent in young men and
most patients reported to be consumers of tobacco and canna-
bis.6 This consumption varies from light to heavy (up to 20
tobacco cigarettes and up to 15 cannabis cigarettes a day).4
Figure 1 An exudative ulcerated lesion partially covered by a necrosis
plaque on the pulp of the left hallux.
Figure 2 Occlusion of the anterior tibial artery and peroneal artery in
both legs.
Figure 3 Occlusion of the plantar arch of both feet. Note the arterial
poverty of the feet.
Figure 4 Occlusion of the supra-articular popliteal artery in the left
leg. Note the collateral vessels.
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Interestingly, more than 40% of the patients with thromboangii-
tis obliterans assumed to be also cannabis smokers.7
Clinically, CA manifests with claudication, acral pain, sub-
acute distal ischaemia (predominantly but non-exclusively of the
lower limbs) and early disappearance of distal pulses.5
Doppler ultrasonography and arteriography are the imagiolo-
gical exams of choice to study peripheral arterial diseases.
Unlike atherosclerosis, typical calcified plaques of atherosclerosis
along proximal arteries are usually not seen in CA.3
Arteriography reveals distal segmental stenosis that are often
bilateral, a poor distal vascularisation and a weakly developed
collateral vessels network.6 8 9 In our patient, we found bilateral
occlusion of the peroneal artery, anterior tibial artery and
plantar arch, as well as, of the left popliteal artery. This trans-
lates an extremely severe case.
Comparatively with Buerger’s disease, the only truly effective
treatment of CA is the cessation of the respective consumption.
If this is achieved, the prognosis is excellent but if otherwise,
the patient does not comply, symptoms progress and it can lead
to amputation in up to 40% of cases.3 10 Also if the abuse is
resumed, the disease recurs. Other medical treatments have
been proposed with various results like vasodilator drugs (pros-
taglandins),3 platelet aggregation inhibitors (acetylsalicylic acid)3
or anticoagulant drugs (heparin).5 Hyperbaric oxygen therapy
has been used for severe cases. However, without cessation of
the abuse, none of these therapeutic options are sufficient. The
surgical approach is generally not an option attending to the
distal localisation of the lesions, being the amputation a last
resort for refractory cases.6 8 9
Attending to the similarities in terms of clinical and arterio-
graphic findings and clinical evolution, most authors consider
CA as a subtype of thromboangeiitis obliterans.3 6 10–12 As main
differences, one must highlight obviously the object of
addiction (cannabis vs tobacco) and it seems that the network of
collateral vessels in thromboangiitis obliterans is better
developed than in CA.5
The pathophysiology of CA has been a matter of debate. At
least part of CA pathogenesis can be explained by the vasocon-
strictor effects of ⌂-9-tetrahydrocannabinol, the primary psy-
choactive constituent of cannabis.13 However, attending to the
coabuse of cannabis and tobacco in almost all of patients with
CA, a probable pathogenic role of a possible common contamin-
ant of cannabis and tobacco has been proposed. In this field,
arsenic could be this contaminant, impairing angiogenesis
through inhibition of vascular endothelial growth factor and
inducing endothelial cell apoptosis.10
In conclusion, cannabis is at least a cofactor of arteriopathy
and, as one of the most consumed drugs in the world, asking
about its use should be mandatory in all young patients with
peripheral arterial disease.
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Learning points
▸ Cannabis arteritis (CA) is a probable underdiagnosed cause
of peripheral arterial disease in young patients.
▸ The pathogenic role of ⌂-9-tetrahydrocannabinol and a
possible common contaminant of cannabis and tobacco
have been proposed.
▸ CA is considered a subtype of thromboangiitis obliterans as
the clinical and arteriographic findings are similar in both
diseases.
▸ The main treatment is stop the abuse of cannabis but the
symptoms recur if the abuse is resumed.
▸ Amputation is often needed if cannabis consumption is not
stopped.
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